Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 157

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 157
---
 make such reports available through a public website. In addition to making such reports available on a public  
 website, we currently make our audited consolidated financial statements available to our shareholders at our offices and will only    
 mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC’s proxy solicitation 
 rules.                                                                                                                                 |

<div align='center'>95</div>

Foreign Private Issuer

Under
the Companies Law, companies incorporated under the laws of the State of Israel whose shares are publicly traded, including companies
with shares listed on the Nasdaq Capital Market, are considered public companies under Israeli law and are required to comply with various
corporate governance requirements under Israeli law relating to matters such as external directors, the audit committee, the compensation
committee and an internal auditor. This is the case even if our shares are not listed on a stock exchange in Israel. These requirements
are in addition to the corporate governance requirements imposed by the Listing Rules of the Nasdaq Capital Market, or the Nasdaq Marketplace
Rules, and other applicable provisions of U.S. securities laws to which we are subject (as a foreign private issuer).

Board Practices

Introduction

Our
amended and restated articles of association to be in effect upon completion of this offering provide that we may have between five (5)
and eight (8) directors, including directors who serve as external directors under the Companies Law. Immediately as of the effective
time of the registration statement to which this prospectus relates, our board of directors will consist of five (5) directors. Other
than our external directors (if any), our directors are elected by an ordinary resolution at an annual general meeting of our shareholders.
Our directors are divided into three classes (as nearly equal in number as practicable), class I, class II and class III, that are each
elected at the third annual general meeting of our shareholders, in a staggered fashion (such that one class is elected each annual general
meeting), and serve on our board of directors, unless they are removed by a majority of the shares voted at a general meeting of our
shareholders or upon the occurrence of certain events, in accordance with the Companies Law and our amended and restated articles of
association.

Because
our Ordinary Shares do not have cumulative voting rights in the election of directors, the holders of a majority of the voting power
represented at a shareholders meeting have the power to elect all of our directors up for election or re-election, subject to the special